RT Journal Article SR Electronic T1 SARS-CoV-2 entry related genes are comparably expressed in children’s lung as adults JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.05.25.20110890 DO 10.1101/2020.05.25.20110890 A1 Yue Tao A1 Ruwen Yang A1 Chen Wen A1 Jue Fan A1 Jing Ma A1 Qiao He A1 Zhiguang Zhao A1 Xinyu Song A1 Hao Chen A1 Guocheng Shi A1 Minzhi Yin A1 Nan Fang A1 Hao Zhang A1 Huiwen Chen A1 Xi Mo YR 2020 UL http://medrxiv.org/content/early/2020/05/26/2020.05.25.20110890.abstract AB To explore whether the expression levels of viral-entry associated genes might contribute to the milder symptoms in children, we analysed the expression of these genes in both children and adults’ lung tissues by single cell RNA sequencing (scRNA-seq) and immunohistochemistry (IHC). Both scRNA-seq and IHC analyses showed comparable expression of the key genes for SARS-CoV-2 entry in children and adults, including ACE2, TMPRSS2 and FURIN, suggesting that instead of lower virus intrusion rate, other factors are more likely to be the key reasons for the milder symptoms of SARS-CoV-2 infected children.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board and the Ethics Committee of Shanghai Children's Medical Center (SCMCIRB-K2020034), and written informed consent was obtained from (the parents of) each patient.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be found in the manuscript and the supplementary materials.